Stock listing
Moonlake Immunotherapeutics
Selected listing: MLTX · NASDAQ · USD · US
Moonlake Immunotherapeutics (NASDAQ:MLTX), Health Technology. Latest release Aug 10, 2026: MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1…
- Ticker
- NASDAQ:MLTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Moonlake Immunotherapeutics
Moonlake Immunotherapeutics is a public company listed under the ticker MLTX, operating in the American market. Moonlake focuses on developing innovative immunotherapies to address unmet medical needs.
Latest news from Moonlake Immunotherapeutics
MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results
August 10, 2026
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
June 23, 2026
MoonLake Immunotherapeutics Announces Proposed Public Offering
June 22, 2026
MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
June 21, 2026
MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results
May 9, 2026
Events
Replays
MoonLake Immunotherapeutics (MLTX) Q4 2023 Earnings Call
Sun, Mar 10, 2024 · 12:00 PM ET
Watch
Research Moonlake Immunotherapeutics
Moonlake Immunotherapeutics company profile
View the public company page for Moonlake Immunotherapeutics on 6ix.
Moonlake Immunotherapeutics news
Read company news and market updates connected to Moonlake Immunotherapeutics.
Moonlake Immunotherapeutics investor events
Find investor webinars, events, and replay context for Moonlake Immunotherapeutics.
Alternate listings
MLTX:BOATS
US · USD
Alternate listing for Moonlake Immunotherapeutics; the primary context on this page is MLTX:NASDAQ.
MLTXN:BIVA
MX · MXN
Alternate listing for Moonlake Immunotherapeutics; the primary context on this page is MLTX:NASDAQ.
MLTXN:BMV
MX · MXN
Alternate listing for Moonlake Immunotherapeutics; the primary context on this page is MLTX:NASDAQ.